title: Liver transplantation in cystic fibrosis: a report from Baylor College of Medicine and the Texas Children's Hospital.
abstract: CF affects one of 2000 Caucasians, and approximately 25% are found to have CFLD for which OLT may be indicated. Timing of transplantation, contraindications, and survival are still widely debated. We report the outcomes of OLT for pediatric patients with CFLD from the largest children's hospital in the United States. Our records since September 1998 were analyzed for all patients undergoing OLT for CFLD. Nine patients were then compared to similar patients in the UNOS/OPTN database (n = 155). Survivals were calculated with the Kaplan-Meier method and compared using the log-rank test. All statistics were performed in SPSS 15.0. We performed OLT on nine pediatric patients with CFLD, with age ranging from nine to 17 yr at the time of transplant. Mean survival was 69.2 months; patient and allograft survivals at one and five yr were 88.9%, with one death at day 21 due to Aspergillus fumigatus sepsis. Two patients underwent concurrent multi-organ transplantation. One patient required double lung transplantation four yr after isolated OLT. Comparison to the UNOS/OPTN database revealed a trend toward improved survival. Patients with CF can achieve favorable outcomes after OLT, as we report excellent survivals for pediatric patients with CFLD.
authors.affiliation: Michael E. DeBakey Department of Surgery, Baylor College Of Medicine, Houston, TX, USA.
authors.forename: Theresa R
authors.initials: TR
authors.lastname: Harring
authors.forename: N Thao T
authors.initials: NT
authors.lastname: Nguyen
authors.forename: Hao
authors.initials: H
authors.lastname: Liu
authors.forename: Saul J
authors.initials: SJ
authors.lastname: Karpen
authors.forename: John A
authors.initials: JA
authors.lastname: Goss
authors.forename: Christine A
authors.initials: CA
authors.lastname: O'Mahony
mesh_terms: D000293:Adolescent; D001228:Aspergillosis / Q000401:mortality; D001232:Aspergillus fumigatus; D002648:Child; D003550:Cystic Fibrosis / Q000401:mortality / Q000628:therapy*; D005260:Female; D006085:Graft Survival; D006776:Hospitals, Pediatric; D006801:Humans; D017093:Liver Failure / Q000401:mortality / Q000628:therapy*; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D012577:Schools, Medical; D018805:Sepsis / Q000401:mortality; D013781:Texas; D013997:Time Factors; D016896:Treatment Outcome